Ovoca Bio | OVG - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
ALKERMES USD 1.86B 56.17M 2026-09
Avita Medical AUD 28.56M 534K 2026-06
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Great Western Mining Corporation EUR 595.79K 109.22K 2025-12
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 1.18B 223M 2026-09
Organon & Co USD 1.19B 187M 2026-09
Ovoca Bio EUR 173K 990K 2025-12
Revvity USD 604.27M 719K 2026-09
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Viatris USD 3.49B 189.1M 2026-09
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06